Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
SEOM guidelines for the management of non-small-cell lung cancer (NSCLC).
Felip E, Garrido P, Trigo JM, López-Brea M, Paz-Ares L, Provencio M, Isla D; Spanish Society of Medical Oncology. Felip E, et al. Among authors: trigo jm. Clin Transl Oncol. 2009 May;11(5):284-9. doi: 10.1007/s12094-009-0356-4. Clin Transl Oncol. 2009. PMID: 19451061
Tumor markers at the time of recurrence in patients with germ cell tumors.
Trigo JM, Tabernero JM, Paz-Ares L, García-Llano JL, Mora J, Lianes P, Esteban E, Salazar R, López-López JJ, Cortés-Funes H. Trigo JM, et al. Cancer. 2000 Jan 1;88(1):162-8. doi: 10.1002/(sici)1097-0142(20000101)88:1<162::aid-cncr22>3.0.co;2-v. Cancer. 2000. PMID: 10618619
Randomized phase II study of vandetanib alone or with paclitaxel and carboplatin as first-line treatment for advanced non-small-cell lung cancer.
Heymach JV, Paz-Ares L, De Braud F, Sebastian M, Stewart DJ, Eberhardt WE, Ranade AA, Cohen G, Trigo JM, Sandler AB, Bonomi PD, Herbst RS, Krebs AD, Vasselli J, Johnson BE. Heymach JV, et al. Among authors: trigo jm. J Clin Oncol. 2008 Nov 20;26(33):5407-15. doi: 10.1200/JCO.2008.17.3138. Epub 2008 Oct 20. J Clin Oncol. 2008. PMID: 18936474 Clinical Trial.
Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology (SEOM).
Colomer R, Alba E, González-Martin A, Paz-Ares L, Martín M, Llombart A, Rodríguez Lescure Á, Salvador J, Albanell J, Isla D, Lomas M, Rodríguez CA, Trigo JM, Germà JR, Bellmunt J, Tabernero J, Rosell R, Aranda E, Cubedo R, Baselga J; Spanish Society of Medical Oncology. Colomer R, et al. Among authors: trigo jm. Ann Oncol. 2010 Feb;21(2):195-198. doi: 10.1093/annonc/mdp595. Ann Oncol. 2010. PMID: 20110291 Free PMC article. No abstract available.
First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patients.
Salazar F, Molina MA, Sanchez-Ronco M, Moran T, Ramirez JL, Sanchez JM, Stahel R, Garrido P, Cobo M, Isla D, Bertran-Alamillo J, Massuti B, Cardenal F, Manegold C, Lianes P, Trigo JM, Sanchez JJ, Taron M, Rosell R. Salazar F, et al. Among authors: trigo jm. Lung Cancer. 2011 Apr;72(1):84-91. doi: 10.1016/j.lungcan.2010.07.008. Epub 2010 Aug 11. Lung Cancer. 2011. PMID: 20705357
Recommendations for the optimal management of early and advanced urothelial carcinoma.
Castellano D, Carles J, Esteban E, Trigo JM, Climent MÁ, Maroto JP, del Muro XG, Font A, Paz-Ares L, Arranz JÁ, Bellmunt J. Castellano D, et al. Among authors: trigo jm. Cancer Treat Rev. 2012 Aug;38(5):431-41. doi: 10.1016/j.ctrv.2011.10.004. Epub 2011 Nov 23. Cancer Treat Rev. 2012. PMID: 22116017 Review.
Immunohistochemical expression of cyclooxygenase-2 in patients with advanced cancer of the larynx who have undergone induction chemotherapy with the intention of preserving phonation.
Pérez-Ruiz E, Cazorla O, Redondo M, Pérez L, Álvarez M, Gallego E, Trigo JM, Medina JA, Matilla A, Rueda A. Pérez-Ruiz E, et al. Among authors: trigo jm. Clin Transl Oncol. 2012 Sep;14(9):682-8. doi: 10.1007/s12094-012-0859-2. Epub 2012 Jul 24. Clin Transl Oncol. 2012. PMID: 22855152
142 results